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Neuronal IFN-beta–induced PI3K/Akt-FoxA1
signalling is essential for generation of
FoxA1þTreg cells
Yawei Liu1, Andrea Marin1, Patrick Ejlerskov1, Louise Munk Rasmussen1, Marco Prinz2
& Shohreh Issazadeh-Navikas1
Neurons reprogramme encephalitogenic T cells (Tenc) to regulatory T cells (Tregs), either
FoxP3þTregs or FoxA1þTregs. We reported previously that neuronal ability to generate
FoxA1þTregs was central to preventing neuroinﬂammation in experimental autoimmune
encephalomyelitis (EAE). Mice lacking interferon (IFN)-b were defective in generating
FoxA1þTregs in the brain. Here we show that lack of neuronal IFNb signalling is associated
with the absence of programme death ligand-1 (PDL1), which prevents their ability to
reprogramme Tenc cells to FoxA1
þTregs. Passive transfer-EAE via IFNb-competent Tenc cells to
mice lacking IFNb and active induced-EAE in mice lacking its receptor, IFNAR, in the brain
(NesCre:Ifnarﬂ/ﬂ) result in defective FoxA1þTregs generation and aggravated neuroinﬂamma-
tion. IFNb activates neuronal PI3K/Akt signalling and Akt binds to transcription factor FoxA1
that translocates to the nucleus and induces PDL1. Conversely, inhibition of PI3K/Akt, FoxA1
and PDL1 blocked neuronal ability to generate FoxA1þTregs. We characterize molecular
factors central for neuronal ability to reprogramme pathogenic T cells to FoxA1þTregs
preventing neuroinﬂammation.
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R
egulatory T cells (Tregs) are essential in controlling
inﬂammation. FoxP3þTreg cells have been shown to
prevent overactivation of the immune system in systemic
and central nervous system (CNS) inﬂammatory diseases1,2.
We have recently identiﬁed a new Treg cell population,
FoxA1þTreg cells, which played a pivotal role in regulation of
CNS inﬂammation3.
The outcome of CNS inﬂammation depends on how immune
cells, vascular cells and neurons interact4. Neurons have evolved
several mechanisms to directly interact with T cells, to protect
against development of chronic CNS inﬂammation. Neurons
have been shown to promote T-cell apoptosis through Fas/FasL
interactions5 and to produce anti-inﬂammatory cytokines,
such as transforming growth factor-b, which in turn prevents
experimental autoimmune encephalomyelitis (EAE)6,7. The
immunoregulatory activities of neurons and their central role in
controlling CNS diseases, partly by regulating CNS inﬂammation,
have recently received profound support3,7–9. We have previously
shown that neurons directly interact with pathogenic T cells;
this subsequently led to the generation of FoxP3þTregs with
capacity to ameliorate EAE7. Moreover, we reported that neurons
were capable of converting EAE-inducing encephalitogenic
T cells (Tenc) to anti-inﬂammatory FoxA1þTregs (ref. 3). Of
note, mice genetically lacking interferon (IFN)-b signalling
developed severe relapsing-remitting and demyelinating EAE,
which subsequently was inhibited upon passive transfer of
neuron-induced FoxA1þTregs cells3. In support, beneﬁcial
IFNb-treatment response in patients with multiple sclerosis
(MS) was associated with increased generation of circulating
FoxA1þTreg cells3.
Here we investigate whether neuronal IFNb is essential
for their capacity to reprogramme Tenc cells to become FoxA1þ
Tregs and furthermore study the molecular signalling by which
IFNb coordinates this central immunoregulatory function of
neurons. We report that IFNb-mediated FoxA1 activation
results in expression of neuronal PDL1. IFNb activates neuronal
PI3K/Akt signalling. Consequently, Akt binds to transcription
factor FoxA1 that translocates to the nucleus and induces PDL1.
This is indispensable for neuronal ability to reprogramme
Tenc cells and generate FoxA1þTregs, which in turn are important
to combat neuroinﬂammation.
Results
Lack of FoxA1þTregs leads to neuroinﬂammation in Ifnb /
mice. Previously with active EAE, we identiﬁed FoxA1þTregs
from CNS-inﬁltrating T cells in IFNb-competent wild-type (WT)
(Ifnbþ /þ ) mice. In the contrary, FoxA1þTregs were not found in
EAE mice genetically lacking IFNb (Ifnb / )3. We have also
reported that IFNb signalling in T cells was central for their
FoxA1þTreg cell fate determination. To exclude the role of
intrinsic IFNb signalling in T cells, we utilized IFNb-competent
Tenc cells (MBP89–101 reactive Tenc cells) to transfer adoptive
EAE in Ifnbþ /þ or Ifnb / mice. As previously reported for the
active EAE3, inducing adoptive transfer of EAE led to higher
clinical disease score in Ifnb / mice (Fig. 1a). This was
associated with defective FoxA1þTreg (TCRþFoxA1þPDL1þ )
cell generation in the CNS-inﬁltrating T cells in Ifnb / spinal
cord in contrast to Ifnbþ /þ mice, day 30 post adoptive EAE
(Fig. 1b); this indicates that despite utilizing the same WT-
MBP89–101 reactive Tenc cells in both groups, the determining
factor is the host endogenous IFNb. Interestingly, although
Ifnb / mice developed signiﬁcantly higher neuroinﬂammation
apparent by elevated total number of inﬁltrating T cells in the
spinal cord even during remission (Fig. 1c), they had signiﬁcantly
lower FoxA1þTregs compared with Ifnbþ /þ mice (Fig. 1d).
Of note, FoxA1þTregs were often detected not only in
perivascular space (Fig. 1b) but also in parenchyma adjacent to
neuronal soma (Fig. 1e); this provides neurons with possibility to
interact with T cells and induce their FoxA1 expression both via
molecules expressed on axons or on neuronal cell bodies, in the
areas that T cells usually invade the CNS remote from neuronal
bodies, as well as closed to the neuronal bodies upon migrating in
the parenchyma, respectively. Moreover, a striking difference
was observed in neuronal PDL1 expression in the cerebellum
and spinal cord, which was lacking in Ifnb / mice (Fig. 1f,g).
Of interest, although PDL1 was not detectable in Ifnb / mice,
FoxA1 was expressed (Fig. 1g). Of interest, the signiﬁcant increase
of FoxA1þTregs in Ifnbþ /þ mice (Fig. 1b,d) was associated
with neuronal co-expression of FoxA1 and PDL1, whereas lack
of IFNb was associated with loss of neuronal PDL1 expression
(Fig. 1g,h) and concomitant loss of FoxA1þTreg cells in the
CNS of Ifnb / mice. These results suggested an important role
for IFNb signalling in the CNS to regulate the generation of
FoxA1þTreg cells.
Nescre:Ifnarﬂ/ﬂ mice lose ability to generate FoxA1þTregs.
To address the role of neuronal IFNb-IFNAR signalling in
regulation of CNS inﬂammation associated with FoxA1þTreg cell
generation, Nescre:Ifnarﬂ/ﬂ mice were actively immunized with
MOG35–55 (ref. 10). Quantiﬁcation of inﬂammatory cells
inﬁltrating in the spinal cord of mice 35 days post
immunization revealed that Nescre:Ifnarﬂ/ﬂ mice developed
profound neuroinﬂammation compared with their
WT corresponding, Ifnarﬂ/ﬂ mice (Fig. 2a,b). Similar to mice
lacking genomic IFNb, loss of brain IFNAR (IFNa/b receptor)
signalling in Nescre:Ifnarﬂ/ﬂ mice resulted in the lack of
FoxA1þTreg-cell generation associated with elevated neuroin-
ﬂammation (Fig. 2c–e). Of note, loss of neuronal IFNAR sig-
nalling led to the loss of PDL1 expression, while FoxA1 was still
expressed by neurons (Fig. 2f,g). Taken together, these results
strongly indicated that active neuronal IFNb-IFNAR signalling is
central for converting Tenc cells to FoxA1þTreg cells and hence
for controlling neuroinﬂammation in the CNS.
Neuronal IFNb signalling is essential to generate FoxA1þTregs.
Although neurons were found to be able to generate FoxA1þTregs
(ref. 3) and the results above supported an active role
for neuronal IFNb signalling, the molecular mechanisms by
which neurons exert such a fundamental immunoregulatory
property were not known. Here we investigated whether neuronal
IFNb was involved in their T-cell-reprograming capacity. To
exclude other CNS-resident cell contribution, we established
primary neuronal cultures with high purity (Fig. 3a) (that is,
mean±s.d. of 98.3±0.28%, n¼ 3) and compared them with
astrocytes and microglial cells in regard to their capacity to
generate FoxA1þTreg cells upon interacting with Tenc cells. As
expected, cerebellar granular neurons (CGNs) changed pheno-
type of activated Tenc cells and generated FoxA1þTregs, whereas
other CNS innate antigen-presenting cells (APCs); microglia and
astrocytes did not exert these properties (Fig. 3b). We have
previously shown that neurons remain electrically active in
culture7. To investigate whether neuronal electrical activity is
required for the induction of FoxA1þTregs, neurons were silenced
by tetrodotoxin (TTX). TTX is a potent toxin that speciﬁcally
binds to voltage-gated sodium channels and blocks the ﬂow of
sodium ions through the channel, thereby preventing action
potential generation and propagation11, and silences neurons12.
TTX-silenced neurons lost the capacity to induce generation of
FoxA1þTregs (Fig. 3c).
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Figure 1 | Adoptive transfer of Tenc cells to Ifnb
 / mice causes elevated neuroinﬂammation associated with defective FoxA1þTreg cell generation.
(a) Adoptive transfer of MBP89–101 Tenc cells to C57BL/10.RIII mice, EAE score from Ifnb
þ /þ and Ifnb / mice, n¼ 24 mice per group. Non-parametric
Mann–Whitney test was used, ***Po0.001. (b) Representative IF images in spinal cords from mice day 30 adoptive EAE. PDL1(green), FoxA1(red),
TCR(purple) and DAPI(blue). Scale bars, 20mm. (c) Quantiﬁcation of number of spinal cord inﬁltrating T cells, (d) quantiﬁcation of number of FoxA1þTreg
cells. Graphs are mean±s.e.m., n¼ 10 sections per group. Non-parametric Mann–Whitney test was used, *Po0.05 and **Po0.01. (e) IF images of T cells
in close vicinity of neurons in spinal cords of a WTmouse, day 30 post-adaptive EAE. FoxA1 (red), TCR (purple) and DAPI (blue). Scale bars, 10mm.
(f) Representative IF images of neurons in cerebellums. PDL1 (green) and NF200 (purple) were stained and shown. Scale bars, 30mm. (g) Closed up
representative IF images of neurons in spinal cords. PDL1 (green), FoxA1 (red), TCR (purple) and DAPI (blue). (h) Quantiﬁcation of number of
NF200þFoxA1þPDL11þ neurons in spinal cords. Graphs are mean±s.e.m., n¼ 7–8 sections per group. Non-parametric Mann–Whitney test was used,
*Po0.05.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14709 ARTICLE
NATURE COMMUNICATIONS | 8:14709 | DOI: 10.1038/ncomms14709 | www.nature.com/naturecommunications 3
We next examined the suppressive capacity of these neuronal-
induced FoxA1þTreg (nFoxA1þTreg) cells in vivo and in vitro.
As previously reported3, puriﬁed nFoxA1þTregs could induce
signiﬁcant cell death of activated Tenc cells in vitro (Fig. 3d). To
conﬁrm their suppressive activities in vivo, puriﬁed nFoxA1þTregs
were adoptively transferred to ears in a murine delayed-type
hypersensitivity (DTH) model of tissue inﬂammation. Ears
receiving nFoxA1þTregs had signiﬁcantly less inﬂammation
(Fig. 3e). These results supported suppressive and anti-
inﬂammatory properties of FoxA1þTregs in vivo and in vitro.
We ﬁnally examined the need for endogenous neuronal IFNb
in generation of FoxA1þTregs. We observed that both CGNs and
cortical neurons (CNs) from Ifnbþ /þ neurons were able to
generate FoxA1þTregs, whereas neurons lacking IFNb (Ifnb / )
lost this capacity (Fig. 3f–h). Treatment of Ifnb / neurons
with recombinant (r)IFNb to reconstitute their defect, before
co-culture with activated Tenc cells, restored their ability to
generate FoxA1þTregs (Fig. 3i). These data indicated that
neuronal ability to convert pathogenic Tenc cells to FoxA1þTreg
cells depends on their endogenous IFNb signalling. IFNb share
many functional similarities with IFNa, as they share the same
receptor, IFNAR; however, they also differ in many of
their functions including their different efﬁciencies as disease
treatment. Although it is not well described how IFNb might
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Figure 2 | Defective neuronal IFNb-IFNAR signalling in Nescre:Ifnarﬂ/ﬂ mice leads to loss of capacity to generate FoxA1þTregs. (a) Quantiﬁcation of
number of inﬁltrating inﬂammatory cells in spinal cords in Ifnarﬂ/ﬂ (WT) and NesCre:Ifnarﬂ/ﬂ mice with active EAE. Graphs are mean±s.e.m., n¼6 per
group. Non-parametric Mann–Whitney test was used, *Po0.05. (b) Representative spinal cord sections stained with H&E day 35 post EAE immunization.
Scale bars, 200mm. (c) Overview of IF images of spinal cords. PDL1 (green), FoxA1 (red), TCR (purple) and DAPI (blue). Scale bar, 50mm. (d) Closed up
IF images of representative spinal cords. PDL1 (green), FoxA1 (red), TCR (purple) and DAPI (blue). Scale bars, 50 mm. (e) Quantiﬁcation of FoxA1þTreg cells
in spinal cords. Graphs are mean±s.e.m., n¼ 12 sections per group. (f) Closed up IF images of representative spinal cords. PDL1 (green), FoxA1 (red),
NF200 (purple) and DAPI (blue). Scale bars, 20mm. (g) Quantiﬁcation of NF200þFoxA1þPDL1þ neurons in spinal cords. Graphs are mean±s.e.m.,
n¼ 12 sections per group. Non-parametric Mann–Whitney test was used, ***Po0.001.
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Figure 3 | Neuronal capacity to generate FoxA1þTreg cells requires IFNb. (a) One representative IF image from neuronal culture was stained with
anti-GFAP (yellow) and anti-b III tubulin (green). Scale bar, 100 mm. (b) Percentage of FoxA1þTreg cells were analysed by FACS after co-culture of activated
Tenc cells with CG neurons, microglial or astrocytes, respectively. Graphs are mean±s.e.m., n¼ 3. One-way analysis of variance (ANOVA) test was used,
***Po0.001. (c) Percentage of FoxA1þTregs were analysed by FACS after co-culture of Tenc cells with CGN treated with or without TTX (1mM) for 24 h
before co-culture. Graphs are mean±s.e.m., n¼ 3, one-way ANOVA test was used, ***Po0.001. (d) Percentage of 7AADþ (dead) cells was analysed by
FACS. Res, responder T cells were activated with plate-bound anti-CD3 (1 mgml 1) and soluble anti-CD28 (2mgml 1) for 24 h, then co-cultured with
neurons to generate FoxA1þTreg cells (nFoxA1þTreg) for another 24 h. Graphs are mean±s.e.m., n¼ 3. Unpaired Student’s t-test was used, ***Po0.001.
(e) DTH measured as ear thickness at 24 and 48 h post injection of nFoxA1þTreg or control cells (ctrl-T). Graphs are mean±s.e.m., n¼ 3 mice per group.
Unpaired Student’s t-test was used, *Po0.05. (f) FoxA1þTreg cell FACS gating strategy. (g) Gated CD4highPDL1high cells (R1) and CD4lowPDL1low cells
(R2). (h) Percentage of FACS analysis of FoxA1þTregs after co-culture of Tenc cells with CGN or CN. Graphs are mean±s.e.m., n¼ 3, one-way ANOVA test
was used, **Po0.01 and ***Po0.001. (i) Percentage of FoxA1þTregs were analysed by FACS after co-culture of Tenc cells with CGN treated with or without
rIFNb (100Uper ml). One-way ANOVA test was used, **Po0.01 and ***Po0.001.
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regulate IFNa, it is previously reported that IFNb is required
for production of IFNa in ﬁbroblast13 and we have not detected
any compensatory mechanisms in neurons when only IFNb is
deleted9. Although IFNa might have additional or differential
effects independent of IFNb, this has not been observed related
to the neuronal activity. Moreover, there are several alleles
for Ifna, which result in the production of many active
IFNa isoforms. This is imposing much more complexity to
investigate the plausible role for IFNa isoforms in relation to the
neuronal functions and hence not the focus of the current study.
Generation of FoxA1þTregs requires neuronal FoxA1 and PDL1.
Previously, we have shown that the soluble cytokine IFNb has an
anti-inﬂammatory role in the CNS, as evidenced by the extensive
CNS inﬂammation, relapses and demyelination in Ifnb / mice
with EAE14. In addition, it was shown that treatment of T cells
with exogenous rIFNb was sufﬁcient to induce FoxA1þTregs
(ref. 3). To understand whether soluble IFNb produced by
neurons directly affects Tenc cells to change their phenotype to
FoxA1þTregs, we utilized a transwell system to separate neurons
and T cells in co-cultures, allowing free circulation of IFNb.
Separation of neurons from Tenc cells completely diminished
FoxA1þTreg cell generation (Fig. 4a), which suggests that cell-to-
cell contact is necessary for neuronal conversion of pathogenic
Tenc cells to anti-inﬂammatory FoxA1þTregs.
It was established that neuronal signaling molecule PDL1
inhibited cell cycle and induced apoptosis in brain tumours,
namely glioblastoma8; however, it was not known whether it
could be involved in interaction between neurons and T cells.
In T cells, IFNb treatment activates the transcription factor
FoxA1 and thereby transcription of its downstream target gene
Pdl1 (ref. 3). Earlier, FoxA1 has been reported to play a role in
survival of dopaminergic neurons15; however, it was unknown
whether IFNb has an impact on neuronal regulation of FoxA1 or
whether FoxA1 targets the Pdl1 gene in neurons. We
hypothesized that upon IFNb treatment, neurons would
activate FoxA1 to induce transcription of Pdl1. The lack of
neuronal PDL1 expression both in Ifnb / and Nescre:Ifnarﬂ/ﬂ
mice strongly supported such a scenario. We therefore examined
the messenger RNA expression levels of Foxa1 and Pdl1 in
CGNs, with or without rIFNb treatment. FoxA1 and Pdl1 mRNA
were signiﬁcantly increased after rIFNb stimuli (Fig. 4b,c). We
also found remarkable differences in the basal levels of FoxA1 and
PDL1 proteins in Ifnbþ /þ and Ifnb / neurons, which were
further increased upon rIFNb treatment (Fig. 4d–h). Moreover,
treatment of Ifnbþ /þ neurons with rIFNb led to an increased
translocation of FoxA1 from the cytoplasm to the nucleus
(Fig. 4f,g). In addition, we identiﬁed a striking difference in the
subcellular localization of FoxA1 in Ifnbþ /þ versus Ifnb /
neurons: although FoxA1 was mainly found in the perinuclear
space in Ifnbþ /þ neurons and translocated to the nucleus upon
rIFNb treatment, in Ifnb / neurons FoxA1 was almost
exclusively nuclear (Fig. 4g). Of note, the neuronal marker
NF200 was also detected in the nucleus, the precise function of
which is not well deﬁned; an explanation for this observation
might be the fact that neuroﬁlaments are used as ducking or
carriage proteins to transport signalling molecules.
We next investigated whether FoxA1 and its downstream
target PDL1 were necessary for neuronal capacity to generate
FoxA1þTregs. PDL1 was found to be much lower in Ifnb /
neurons and rIFNb signiﬁcantly upregulated PDL1 protein in
both Ifnbþ /þ and Ifnb / neurons as previously reported by
us8. To study the function of neuronal FoxA1 and PDL1,
knockdown (KD) of neuronal FoxA1 and PDL1 was successfully
achieved using small-interfering RNAs (siRNAs) (Fig. 4i,j,l).
Importantly, neuronal FoxA1 KD led to reduced PDL1 expression
(Fig. 4i,j), indicating that, as in T cells3, Pdl1 is a target gene for
FoxA1 in neurons. Moreover, KD of FoxA1 or PDL1 in neurons
before co-culture with Tenc, signiﬁcantly reduced their capacity to
convert Tenc cells to FoxA1þTregs (Fig. 4k,m). In support,
blocking neuronal PDL1 signalling in the Ifnbþ /þ neurons
(using a blocking anti-PDL1 antibody) or blocking PD1 on
Tenc cells (using a blocking anti-PD1 antibody) resulted
in inhibition of FoxA1þTreg cell generation (Fig. 4n).
Moreover, overexpressing PDL1 (using the pIRESII PDL1
plasmid) on Ifnb / neurons restored their ability to generate
FoxA1þTreg cells (Fig. 4o,p). These results conclusively
underscores that defective neuronal FoxA1 and PDL1 could
account for the decreased or lack of ability to induce
FoxA1þTregs, and that IFNb signalling is central for activation
of neuronal FoxA1 and its target gene Pdl1, which in turn are
indispensable for the function of neurons to interact and convert
pathogenic T cells to FoxA1þTreg cells.
IFNb-induced PI3K/Akt regulates neuronal FoxA1 and PDL1.
It is known that JAK (Janus kinase) and a STAT (signal trans-
ducer and activator of transcription) pathway is activated
by IFNs; however, the importance of many other pathways in
IFN-mediated signalling is also established16–20. Here we aimed
to characterize the downstream signalling pathway for IFNb,
which regulates neuronal FoxA1-mediated transcription of Pdl1.
We investigated different pathways activated by IFNb, including
P38 mitogen-activated protein kinases (p38 MAPK), MAPK3
(Erk1), MAPK1 (Erk2), phosphatidylinositol-3-kinases (PI3Ks)
and protein kinase B (Akt). We detected signiﬁcant differences
regarding higher basal Pi3k and Akt mRNA and protein levels in
Ifnbþ /þ versus Ifnb / neurons (Fig. 5a–e). Phosphorylated
(p)PI3K and pAkt are signs of active signalling molecules,
which were even more pronouncedly reduced in Ifnb /
neurons compared with the IFNb-competent neurons. Reduced
pPI3K/pAkt in Ifnb / neurons were also associated with
signiﬁcant lower FoxA1 and PDL1 (Fig. 5b,c). Moreover, we
found an abundant Pi3k and Akt transcription (Fig. 5d,e) and
protein induction upon IFNb treatment of neurons; however,
here were no differences detected for pErk and pP38 (Fig. 5f).
These data suggested that PI3K/Akt might act upstream of
IFNb-induced FoxA1-PDL1 regulation. To address this issue, we
chemically inhibited PI3K and Akt signalling in Ifnbþ /þ
neurons, which completely eliminated IFNb-induced FoxA1
and PDL1 expressions in neurons (Fig. 5f–h).
Next, we examined whether Akt physically binds to FoxA1 in
regards to activate the pathway leading to PDL1 induction.
In support of this scenario, when we overexpressed FoxA1 with
a ﬂag-tag in neuronal cell line N2A, we could immunoprecipitate
(IP) FoxA1, leading to pull down of endogenous Akt upon co-IP
(Fig. 5i), which was conﬁrmed by IP of endogenous FoxA1 and
co-IPing Akt upon rIFNb treatment of N2A and primary neurons
(Fig. 5j,k), respectively. Our results provided direct evidence that
IFNb-induced PI3K/Akt signalling is essential for the induction
of FoxA1 and subsequently PDL1 in neurons.
Neuronal PI3K/Akt is essential to reprogramme T cells. We
demonstrated that engagement of PI3K/Akt pathway was
required for IFNb-mediated neuronal expressions of FoxA1
and PDL1. To establish whether the PI3K/Akt signalling is
required for neurons to convert Tenc cells to FoxA1þTregs,
we blocked neuronal PI3K and Akt activities using either
PI3K inhibitor or KD of Akt by siRNA silencing before neurons
were co-cultured with encephalitogenic Tenc cells. Inhibition
of PI3K/Akt signalling in neurons signiﬁcantly reduced the
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protein levels of FoxA1 and PDL1 (Fig. 5), and resulted in
complete abrogation of their function to convert Tenc cells to
FoxA1þTregs (Fig. 6a–c). Collectively, our data revealed that
endogenous IFNb signalling is central for the immunoregulatory
function of neurons in which they convert pathogenic T cells to
become FoxA1þTregs. We showed that IFNb triggers PI3K/Akt
activation and Akt subsequently bound to FoxA1. This
process in turn activated neuronal FoxA1 to induce PDL1.
We also established that IFNb-induced PI3K/Akt pathway
and its downstream FoxA1-mediated PDL1 expression were
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indispensable for the immunoregulatory function of neurons to
generate FoxA1þTregs (Fig. 6d).
Discussion
The concerted action between immune cells and tissue-speciﬁc
cells in their microenvironment is crucial for the outcome
of inﬂammation. Autoimmune inﬂammation is a key element
in numerous CNS diseases. The bidirectional interaction between
autoreactive (CNS antigen-speciﬁc) immune cells with brain-
resident cells could therefore be central for the fate
of autoimmune-mediated inﬂammatory diseases such as MS.
CNS-speciﬁc autoimmunity is chieﬂy related to how autoreactive
T and B cells cause damage and/or mutually interact with
CNS-resident APCs to consequently maintain chronic activation
of autoreactive cells and thereby neuroinﬂammation21–24. An
important role of local neurons in regulation of brain immunity is
conceivable; however, it has only recently received more
attention. A direct role in immune regulation was reported for
neurons to promote T-cell apoptosis5. In support, neuronal
nuclear factor, nuclear factor-kB was also shown to regulate
neuroinﬂammation25. Moreover, we reported several pivotal
immunosuppressive properties of neurons, in which neurons
interact with autoreactive Tenc cells and convert them to
regulatory FoxP3þTreg via production of transforming growth
factor-b and expression of B7.1 (ref. 7), and/or converting
them to adapt a FoxA1þTreg fate and anti-inﬂammatory
functions3.
Although the accumulative evidence is reinforcing the
importance of neurons in controlling CNS immunity, current
understanding of the essential basic molecular mechanisms of
neuronal control of neuroinﬂammation is sparse. Here we
investigated the required molecular signalling operative in
neurons, which provides them with capacity to convert
pathogenic T cells to the newly identiﬁed FoxA1þTreg cells and
their impact on outcome of neuroinﬂammation. As mice lacking
the Ifnb gene were deﬁcient in generating FoxA1þTregs in the
CNS3, we studied the function of endogenous neuronal IFNb
when challenged with IFNb-competent Tenc cells. Neurons
defective in IFNb production were incompetent to convert Tenc
cells to FoxA1þTregs, both in vitro and in vivo, indicating a
central function of this cytokine in neuronal immunoregulatory
efﬁcacies. In support, neuronal IFNb was shown to be critical for
their anti-tumor functions to control glioblastoma8. Soluble IFNb
was shown to exert anti-tumour activities16,26 and it was
sufﬁcient to convert naive T cells to FoxA1þTregs (refs 3,27).
However, blocking the direct cell-to-cell interaction between
neurons and T cells prevented the conversion of Tenc to
FoxA1þTregs, which revealed that released soluble neuronal
IFNb alone was not sufﬁcient to convert T cells. These data
suggested that endogenous neuronal IFNb exerted paracrine and
autocrine effects to provide neurons with additional signalling key
molecules. In support, lack of IFNAR on neurons was leading to
the similar loss of function in NesCre:Ifnarﬂ/ﬂ mice, which strongly
displayed evidence that released soluble IFNb by neurons9
requires active autocrine signalling, via its receptor, to
synchronize neuronal immunoregulatory functions. Pleiotropic
biological activities of IFNb was reported to be mediated
by triggering different signalling pathways16. We demonstrated
that the PI3K/Akt pathway was activated downstream of
neuronal IFNb signalling. In agreement, PI3K has been shown
to be responsible for several biological activities of IFNa/b in
different types of cells even independent of JAK–STAT
signalling28–30. Activation of PI3K and Akt were essential for
induction of other downstream signalling molecules in neurons.
We showed that Akt binds to FoxA1. As a transcription factor,
the role of FoxA1 in neurodevelopmental processes and survival
of dopaminergic neurons has been reported15, but no role was
established related to immunoregulatory function of post-mitotic
neurons, in particular related to IFNb signalling. Interestingly,
in vivo, FoxA1 could be detected in neurons depleted of IFNb
or IFNAR, but lack of active signalling did prevent it from
targeting the Pdl1 gene, suggesting that activation of PI3K and
Akt could modify FoxA1 activity. Indeed, insulin-like growth
factor-I was reported to increase the stability of FoxA1 protein in
MCF7 breast cancer cell line via Akt pathway31.
Our data suggest that activated Akt binds to FoxA1, which might
mediate its translocation to the neuronal nucleus and upon binding
to the Pdl1 promoter induces its production. In support, we have
previously shown that translocation of FoxA1 to nucleus of T cells
resulted in FoxA1-mediated transcription of the transmembrane
signalling protein PDL1 (ref. 3). The engagement of PDL1 on
T cells with its receptor, programmed death 1 on APCs has been
shown to induce anti-proliferative effects32. Here we identiﬁed that
PDL1 is essential for neurons to bind to PD-1 on Tenc cells and
convert them to FoxA1þTregs. IFNb is also produced by CNS-
resident glial cells14,33, which during neuroinﬂammatory process in
EAE also express PDL1 (refs 34–36). Hence, this posts the question
of why, unlike neurons, glial cells were incapable of converting Tenc
cells to FoxA1þTregs. It is plausible that these immunoregulatory
capabilities of neurons are attributed to the fact that neurons, in
contrast to glial cells, do not express major histocompatibility
complex class II nor produce the predominant proinﬂammatory
cytokines7,37,38, and therefore incapable of conducting a full-
activation signal in T cells, but rather exert tolerogenic signal and
hence cause a different outcome for Tenc cells. Understanding these
Figure 4 | Generation of FoxA1þTreg cells requires neuronal FoxA1 and PDL1. (a) Percentage of FoxA1þTregs upon co-culture of Tencs with CGNs, with or
without transwell. Graphs are mean±s.e.m., n¼ 3. One-way analysis of variance (ANOVA) test was used, ***Po0.001. (b) Fold change of Foxa1 mRNA
and (c) Pdl1 mRNA in CGNs treated with or without rIFNb (100Uml 1). Graphs are mean±s.e.m., n¼ 3, two-way ANOVA test was used, *Po0.05 and
**Po0.01. (d) Foxa1 and (e) Pdl1 mRNA in CGNs (left) and quantiﬁcation (right). Graphs are mean±s.e.m., n¼ 3, Student’s t-test was used, ***Po0.001.
(f) Cytosolic (Cyto) and nucleus (Nu) fractions from CN (left). Graph shows normalized optical density (IOD) ratios between cytosolic/nucleus fractions of
quantiﬁed FoxA1 protein bands (right). Graphs are mean±s.e.m., n¼ 2–4. Non-parametric Mann–Whitney test was used for comparison of treated groups
with control group. *Po0.05 and **Po0.01. (g) CGNs with or without treatment with rIFNb. NF200 (green), FoxA1 (red) and DAPI (blue). Scale bars,
5 mm. (h) WB of FoxA1, PDL1 and vinculin in CNs extracts with or without treatment with rIFNb. (i) Representative FACS histogram of neuronal FoxA1 and
PDL1 after Foxa1 siRNAKD in CGNs and (j) WB of FoxA1, PDL1 and vinculin after Foxa1 siRNAKD in CGNs. (k) Percentage of FoxA1þTregs after co-culture
of Tencs with CGNs after Foxa1 or control siRNAKD in CGNs. Graphs are mean±s.e.m., n¼ 3, Student’s t-test was used, ***Po0.001. (l) Neuronal
PDL1 after Pdl1 or UNC (Universal Negative Control) siRNAKD in CGNs. (m) Percentage of FoxA1þTregs upon co-culture of Tencs with CGNs after PDL1 or
UNC siRNAKD in Ifnbþ /þ CGNs. Graphs are mean±s.e.m., n¼ 3, Student’s t-test was used, ***Po0.001. (n) Percentage of FoxA1þTregs upon co-culture
of Tencs with CGNs after PDL1 was blocked in Ifnb
þ /þ neurons utilizing anti-PDL1 or PD1 was blocked in Tencs utilizing anti-PD1 antibodies. Graphs are
mean±s.e.m., n¼ 3, one-way ANOVA test was used, ***Po0.001. (o) Neuronal PDL1 after transfection of pIRES2-EGFP-PDL1 or pIRES2-EGFP in CGNs.
(p) Percentage of FoxA1þTregs upon co-culture of Tencs with overexpression of PDL1 in Ifnb / CGNs. Graphs are mean±s.e.m., n¼ 3, one-way ANOVA
test was used, ***Po0.001.
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pathways and the possible defects are imperative for designing
future therapeutic approaches for chronic and progressive
neuroinﬂammatory conditions such as progressive MS.
Methods
Mice. Ifnb / mice were backcrossed to C57BL6 or C57BL/10.RIII strains of
mice over 20 generations3. The WT littermates were used (Ifnbþ /þ ) as controls.
Mice were purchased from The Jackson Laboratroy, USA. The mice were bred
and kept at conventional animal facilities at the University of Copenhagen.
One- to 7-day-old newborn pups were used in neuron-culture experiments.
Eight- to 12-week-old Ifnb / and WT mice3 or nesCre:Ifnarﬂ/ﬂ (Ifnar gene
targeting only in neuroectodermal cells) and their WT littermates (Ifnarﬂ/ﬂ)
were used for inducing EAE10.
All experiments were performed in accordance with the ethical committees in
Copenhagen, Denmark and approved by the respective Institutional Review Boards
(2013-25-2934-00807). Regarding the age and gender, mice were equally allocated
to experimental groups.
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Figure 5 | Activation of PI3K/Akt signalling regulates neuronal FoxA1 and PDL1. (a) Real-time PCR analysed fold changes of Pi3k and Akt mRNA in
CGN. Graphs are mean±s.e.m. from three independent experiments. Two-way analysis of variance (ANOVA) test was used, *Po0.05. (b) WB of CGNs
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Two-way ANOVA test was used, *Po0.05 and **Po0.01. (d) Pi3k and (e) Akt mRNA fold changes obtained by real time PCR in CGNs with and without
rIFNb treatment (normalized to GAPDH, as housekeeping gene). Graphs are mean±s.e.m. from three independent experiments. Two-way ANOVA test
was used, ***Po0.001. (f–h) Effects of PI3K inhibitor (Wortmannin in DMSO, 200nm) and Akt inhibitor (MK-2206 in DMSO, 1 mM) in the presence
or absence of rIFNb (100Uml 1) in CGNs. PI3K, pPI3K, Akt, pAkt, pErk, pP38, FoxA1 and PDL1 expressions by WB (f). (g) Representative FACS of PI3K,
Akt, FoxA1 and PDL1 expressions in CGNs and (h) quantiﬁcation of protein expression by FACS. Graphs are mean±s.e.m., n¼ 3. Two-way ANOVA test
was used, **Po0.01 and ***Po0.001. (i) Co-IP of Akt with FLAG-tagged FoxA1 after overexpression of FoxA1-FLAG pCDNA3.1 in N2A cells. (j) Co-IP of
Akt with rIFNb-induced endogenous FoxA1 in N2A cells. (k) Co-IP of Akt with rIFNb-induced endogenous FoxA1 in primary neurons.
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Induction of neuroinﬂammation EAE. To establish neuroinﬂammation in the
CNS, active or adoptive EAE14 was induced in Ifnb / or their WT mice or in
nesCre:Ifnarﬂ/ﬂ (ref. 10). Active EAE was induced with MBP89–101 or MOG35–55,
respectively10,14. Each animal was subcutaneously immunized in the base of the tail
with 100 ml of a 1:1 emulsion of 150 mg of MOG35–55 or 250 mg of MPB89–101
(Schafer-Copenhagen) in PBS and complete Freund’s adjuvant (CFA) containing
500mg of Mycobacterium tuberculosis H37Ra (Difco). An intraperitoneal injection
of 500 ng of pertussis toxin/PT (Bordetella pertussis; Sigma-Aldrich) dissolved in
100ml of PBS was given on the day of immunization (day 0). Mice were observed
for clinical signs of EAE every day. For adoptive transfer EAE, mice were irradiated
(500 rad) and injected in the tail vein with a cell suspension of MBP89–101-speciﬁc
T cells. At day 0 and 2, each animal was given an intraperitoneal injection of 500 ng
of pertussis toxin. The reason for utilizing two different models of EAE either in
C57BL/6 or C57BL/10RIII backgrounds was to address both chronic EAE induced
by MOG35–55, which is commonly used because of the availability of many
transgenic strains in the C57BL/6 genetic background, and to utilize a relapsing-
remitting EAE model induced by MBP89–101, which is the model for relapsing–
remitting MS in C57BL/10RIII background10,14. In addition, such an approach
excludes the possible bias introduced by slight differences in the genetic
backgrounds (C57BL/6 versus C57BL/10RIII) rather than the function of the target
genes, here Ifnb and Ifnar.
Clinical scoring for EAE was as follows: 0, no disease; 1, limp tail; 2, limp tail
and ataxia, as well as hind limb weakness/unsteady walk; 3, both hind limbs
affected; 4, complete paralysis of hind limbs until hips; and 5, moribund or dead.
DTH response. Mice aged 8–15 weeks were immunized with 250 mg of MBP89–101
emulsiﬁed in 50 ml of PBS and 50ml of CFA. At day 13 p.i., mice were injected with
100mg of MBP89–101 (in PBS)þ FoxA1þTregs (3 104 cells per ear) in the right ear
or 100mg of MBP89–101þ control T cells (3 104 cells per ear) in the left ear.
Control mice received an injection of 100 mg of MBP89–101 in the left ear and
PBSþ control T cells (3 104 cells per ear) in the right ear. DTH response was
measured as the difference in thickness (mm) of the right and left ears after 24 and
48 h, respectively. Data for the control T-cell group are presented as: (ear thickness
after injection with MBP89–101þ control T cells) (ear thickness after injection
with MBP89–101). Data for the FoxA1þTregs-treated groups are presented as:
(ear thickness injected with MBP89–101þ FoxA1þTregs) (ear thickness after
injection with MBP89–101).
Neuronal cultures. Two or three mice per group were pooled for each indepen-
dent experiment. Neurobasal medium (ThermoFisher, 21103049) was supple-
mented with 2% B27 (B-27 supplement, serum free, ThermoFisher, 17504044),
1% Penicillin–Streptomycin and 125ml glutamine (200mM, ThermoFisher,
25030081). Culture plates with 96 or 24 wells were coated with poly-D-lysine
(70 mgml 1, P7280, Sigma-Aldrich) in sterile distilled water, incubated for at
least 30min and washed with sterile distilled water.
CGNs cultures were obtained by decapitating a 7-day-old mouse, whereas
CNs were dissected from 1-day-old pup brains. The brains were placed
immediately in a 50ml tube with Hank’s balanced salt solution (HBSS) on ice,
before dissecting in a Petri-dish containing 1ml HBSS in a sterile hood. The
cerebellum and cortex were dissected out and kept intact, while meninges were
removed. A single-cell suspension was prepared by adding trypsin to a ﬁnal
concentration of 200mgml 1. DNAse and FCS were added to ﬁnal concentrations
of 0.12% and 0.5%, respectively, before incubation for 6min. Finally, the tissue was
mechanically dissociated to single cells using a ﬁre-constricted Pasteur pipette and
cells were seeded at a concentration of 4 105 cells per ml. CGNs were cultured for
3–5 days and CNs for 21 days before co-culture with T cells.
Immunoﬂuorescence staining of neurons. CGNs from Ifnbþ /þ and Ifnb /
mice were cultured 3 days in vitro on eight-well LabTek chamber slides (Nunc).
Cells were ﬁxed in 4% paraformaldehyde, permeabilized with 0.2% TritonX-100
and stained with NF-200 (N4142, 1:150, Sigma-Aldrich) and mouse anti-human
(mouse) FoxA1 antibody (2F83, 1:200 Millipore). Hoechst 33342 (H3570, 1:2,000,
Invitrogen) was used for staining nuclei. For measuring the neuronal culture purity,
anti-glial ﬁbrillary acidic protein (GFAP) (13-0300, 1:800, Invitrogen) and anti-b
III tubulin (ab52901-100, 1:100, Abcam) were used to stain the cells and then
positive cells were counted in at least ten randomly selected areas per culture
in three independent experiments.
Glial cell culture. Primary mixed glial cell cultures were established from the
forebrain and cerebellum of 1- to 2-day-old B10.RIII (Ifnbþ /þ ) mice. The
tissues were carefully dissected out and freed of meninges before being placed in
HBSS solution supplemented with 1mM pyruvate and 11mM glucose. Tissue was
then chopped into smaller pieces using a razor blade and incubated with 1% trypsin
(Sigma-Aldrich) for 10min at 37 C. Thereafter, DNase and FCS were added
to a ﬁnal concentration of 0.12% and 0.5%, respectively, and incubated for
8min. Finally, the solution was mechanically dissociated to single cells using
a ﬁre-constricted Pasteur pipette. The cells were seeded at a concentration of
1.5 105 cells per cm2 in a 1:1 mix of DMEM and F12 medium (Invitrogen Life
Technologies) supplemented with 0.16 mMml 1 penicillin, 0.03 mMml 1
streptomycin and 5% FCS. Medium was changed every third to fourth day.
After 7 days in culture, oligodendrocytes were detached from the cell monolayer by
shaking on an orbital shaker. After two to three passages, which initially consisted
of a mixture of 20–30% Mac-1þ microglia and 70–80% GFAPþ astrocytes, these
cultures were further enriched. After 8 days in culture, the mixed glial cells were
washed and vigorously shaken at 900–1,000 r.p.m. for 3 h on an orbital shaker. For
microglial cultures, the ﬂoating cells were collected, washed and reseeded in 96-well
plates (Nunc) at a concentration of 1 104 cells per well. After adhering overnight,
nonadherent or loosely attached cells were washed away. The adherent cells
represented 497% pure microglial cells as determined by Mac-1þ staining, with
o3% being GFAPþ . For astrocyte cultures, the still adherent cells were trypsinized
and reseeded in ﬂasks and left to adhere for 30min. Floating or loosely attached
cells were recovered by mild shaking by hand and the adhesion for 1 h. Cells in the
supernatant were thereafter collected, washed, and reseeded in 96-well plates
(Nunc) at a concentration of 4 104 cells per well. These cells were 496% pure
astrocytes as determined by GFAPþ staining,o4% were Mac-1þ cells. Both these
cultures were then used for coculture with T cells.
Establishment of Tenc cell lines. To generate T-cell lines, 8- to 12-week-old
male B10RIII (Ifnbþ /þ ) were immunized in the ﬂank and tail base with 200 ml of
a 1:1 emulsion of 250 mg of MBP89–101 in PBS and CFA containing M. tuberculosis
H37Ra (Difco). MOG35–55 T-cell line was generated by immunized with C57BL6
mice with 150 mg of MOG35–55. Draining lymph nodes were collected 10 days after
immunization and a single-cell suspension prepared in PBS by passing through
a sieve. Cells were washed and suspended in DMEM with Glutamax-1 (Gibco)
supplemented with 10mM HEPES buffer, 10% heat-inactivated FCS (Sigma),
100Uml 1 of penicillin, 100mgml 1 of streptomycin and 50mM 2-mercap-
toethanol, to make complete DMEM (cDMEM). Cells were cultured as 5 105 cells
in round-bottomed 96-well culture plates (Nunc) in 200 ml of cDMEM, in
a humidiﬁed 37 C atmosphere containing 5% CO2. T cells were stimulated
for 4 days with 50 mg of MBP89–101. After a resting phase of 8 days in media
supplemented with 800 pgml 1 of interleukin (IL)-2 (obtained from the
supernatant of an IL-2 transfected X63 cell line), T cells were re-stimulated
with 20mg of peptide and irradiated APCs. APC were generated from spleen cells
of syngeneic mice, prepared as described above for lymph nodes with an additional
0.84% NH4Cl treatment to lyse red blood cells, and irradiated with 3,000 rad before
being used at a concentration ten times higher than the T cells. To expand highly
speciﬁc T-cell lines, stimulation was repeated at intervals of 10–30 days. Between
stimulations, the antigen-containing media was removed and the T cells kept
in a resting state in cDMEM supplied with IL-2. The media was changed every
fourth day. In all experiments, T-cell lines had gone through a total of four to ten
stimulation rounds.
Co-culture of neurons with T cells. CGNs and/or CNs were prepared7,8 and
seeded at 4 105 cells per ml in 96- or 24-well plates with neuronal media
for 3 and 21 days, respectively. T-cell lines were re-stimulated with antigen and
APCs for 48 h and are referred to as activated Tenc cells. Neurons and activated
syngeneic Tenc cells were washed twice and co-cultured at a 1:1 ratio for 24 h, unless
stated otherwise. MOG35–55 T-cell line and MBP89–101T-cell line were co-cultured
with neurons from C57BL6 mice and C57BL/10.RIII mice, respectively.
For some experiments, PI3K inhibitor Wortmannin (catalogue number S2758,
Selleckchem), Akt inhibitor MK-2206 (catalogue number S1078, Selleckchem),
rIFNb (12405-1, PBL Assay Science) and anti-PDL1 (10 mgml 1, Anti-Mouse
CD274/B7-H1) Functional Grade Puriﬁed, 16-5982-82, eBioscience) were added to
the CGNs. Anti-PD1 (10 mgml 1, Anti-Mouse CD279/PD-1, 16-9985-82,
eBioscience) was added to T cells before co-cultures.
Quantitative real-time PCR. Total RNA was isolated using a QIAGEN kit
(QIAGEN), reverse transcribed into complementary DNA, and ampliﬁed and
quantiﬁed by SYBR Green (Bio-Rad) detection. Relative mRNA expression
was calculated using GAPDH gene expression as an endogenous reference
(PPM02946E). The primers were purchased from SAbiosciences (Qiagen) as
following: Akt1 (PPM03377G), Foxa1 (PPM04764H), Pdl1 (PPM34637A) and
Pi3k (PPM03374G).
FACS staining and sorting using FACSAria. After washing in FACS buffer
(2% FCS in PBS), cells were incubated with anti-Fc receptor Ab (24.G.2, our
hybridoma collection) at 10 mgml 1. Thereafter, cells were incubated with
biotinylated, ﬂuorescein isothiocyanate (FITC)- or phycoerythrin (PE)-labelled
antibodies. For intracellular staining, cells were ﬁxed and permeabilized using
BD Cytoﬁx/Cytoperm or using ﬁxation and permeabilization solutions from
Human Treg Flow Kit. All antibodies were used at 1–5 mgml 1 and were
allowed to bind for 20min on ice. The antibodies used were as follows: APC or
FITC-anti-mouse CD4 (L3T4, 1:200, BD), FITC or biotin-anti-mouse TCR
(553169, 1:200, BD), PE-anti-mouse PDL1 (MIH5, 1:200, BD), isotype control for
PDL1: PE-rat lgG2a isotype control (eBR2a, 1:200, 8012-4321-025, eBioscience),
mouse anti-human (mouse) FoxA1 antibody (2F83, 1:200, Abcam, catalogue
number ab40868) and secondary Alexa Fluor 488 goat anti-mouse (A-11029,
1:1,000, Invitrogen) or Alexa Fluor 647 goat anti-mouse (558865, 1:1,000,
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Invitrogen), isotype control for FoxA1: puriﬁed mouse lgG1k isotype (MOPC-21,
1:100, BD). Violet-ﬂuorescent reactive dye (L34955, 1:1,000, Invitrogen) was used
for LIVE-DEAD marker.
Cells were acquired with an FACSAria (BD Biosciences) using the FACSDiva
software for acquisition after exclusion of duplets. Dead cells were discriminated in
all staining using the LIVE/DEAD Fixable Dead Cell Stain Kit for 405 nm
excitation (L34955, Invitrogen). FlowJo 8.8.6 (Tree Star) was used for further
analysis.
FoxA1þTreg cells were gated by CD4highPDL1high and FoxA1þ expression.
siRNA silencing. Accell SMART pool siRNA was purchased from Dharmacon
(catalogue number E-046238-00, Thermo Scientiﬁc) and was introduced into
neurons according to the manufacturer’s protocol. Brieﬂy, SMART pool siRNA
combines four different siRNAs to reduce off-target effects. The Accell siRNA is
also designed for optimal delivery to hard-to-transfect cells and no transfection
reagents were required to introduce the siRNAs. The following SMART pool
Accell siRNAs from GE Healthcare were used: Foxa1 (E-046238-00-0005),
Cd274 (E-040760-00-0005) and Akt1 (E-040709-00-0005); for detail siRNA
sequences, please see Table 1.
Western blotting. Proteins were extracted in 300 ml RIPA buffer (Sigma-Aldrich,
R0278) from 3 106 CGNs, 15ml of protein lysate was loaded on 4–12%
SDS–PAGE gels and proteins were blotted onto polyvinylidene diﬂuoride
membranes. The membranes were blocked in 5% skim milk (Sigma-Aldrich,
70166) or 5% BSA in PBS-Tween-20 (0.05%) 1 h room temperature and incubated
with: 1 h room temperature and then with horseradish peroxidase-conjugated
secondary antibodies. The blots were developed using the ECL technique
(Millipore, MA, USA).
The following antibodies were utilized: anti-PI3K (4257, Cell Signaling),
anti-PI3K p85 (phospho Y607) antibody (ab182651, 1:1,000, Abcam), anti-Akt
(9272, 1:1,000, Cell Signaling), anti-Akt (Phospho-Ser473) (4060L, 1:1,000, Cell
Signaling), anti-phospho P38 (T180/Y182) (9211, 1:1,000, Cell Signaling),
anti-phospho ERK (T202/Y204) (9101, 1:1,000, Cell Signaling), anti-FoxA1
(ab23738, 1:1,000, Abcam) and anti-PDL1 (BAF1019, 1:5,000, R&D), and
anti-vinculin (1:100,000, v-9313, Sigma-Aldrich).
In some experiments, CNs were cultured for 7 days and stimulated with rIFNb
for 30, 60 or 120min. Subsequently, the CNs were fractionated into a cytosolic and
nucleus fractions39. Fractions were loaded on 4–12% gels according to cytosolic
protein quantiﬁcation determined by Pierce BCA protein assay kit. The protein
concentrations loaded in the cytosolic fractions were around three times higher
than in the nucleus fraction. Antibodies used were as follows: Polyclonal rabbit
anti-FoxA1 (1:1,000, Abcam catalogue number ab23738), monoclonal mouse anti
GAPDH (1:20.000, Abcam catalogue number ab9484) and polyclonal rabbit anti
TBP (1:500, Santa Cruz catalogue number sc-204) were used.
Images have been cropped for presentation. Full-size images are presented in
Supplementary Figs 1–4).
Amaxa transfection of Pdl1 siRNA or pIRESII PDL1. Neurons (5 106) from
B10RIII Ifnbþ /þ mice were transfected with 10 mM of a Pdl1 siRNA
(SASI_Mm02_00326460, MISSION siRNA, Sigma-Aldrich) or a control siRNA
UNC-1 (universal negative control-1) (Sigma-Aldrich) using the Amaxa nucleo-
fector technique (programme G13) according to the manufacturer’s description
(Mouse Neuron Nucleofector Kit, VPG-1001, Lonza, Basel, Switzerland).
Ifnb / mouse neurons (5 106) were transfected with 10 mg pIRES2-EGFP-
PDL1 or pIRES2-EGFP control using the Amaxa nucleofector technique
(program G13) according to the manufacturer’s instructions (Clontech). After 72 h,
neurons were co-cultured with activated Tenc cells or cultured alone in 96-well
plates. Cells were then collected, stained and were analysed by FACS analysis. To
evaluate transfection efﬁciency, some of the neurons were stained with PE-anti-
PDL1 (1:200, MIH5, BD) for FACS analysis.
Co-immunoprecipitation. N2A cells (Sigma-Aldrich) were lipofectamine
transfected (Lipofectamine 2000, Invitrogen, Opti-MEM 1X Reduced-Serum
Medium, GIBCO by Life Technologies) according to the manufacturer’s protocol
with FoxA1-FLAG pCDNA3.1 (2mg DNA per ml) for FoxA1-FLAG IP. Cells were
harvested 48 h after transfection in NP-40 1% lysis buffer (NaCl 150mM, NP-40
1.0%, TRIS pH 8, 50mM) supplemented with phosphatase and protease inhibitors.
For the IP of endogenous FoxA1, N2A cells or primary isolated neurons were
treated with rIFNb (100Uml 1) for 2 h before lysis in a minimum volume of
RIPA buffer (R0278, Sigma) with protease and phosphatase inhibitors. The
RIPA lysates were supplemented with NP-40 1% lysis buffer for the IP procedure.
The lysates were precleared with Sepharose protein G beads (Protein G
Sepharose 4 Fast Flow, GE Healthcare) before incubation with capture antibody
(4 mgml 1) (monoclonal a-FLAG M2, F1804-50UG, Sigma, its isotype control
mouse IgG1, k, 554121, BD Pharmingen, and a-FoxA1, ab5089, Abcam, and its
isotype control goat IgG, ab37373, Abcam) on rotation at 4 C overnight.
The IP lysates were incubated with 50 ml sepharose beads per ml lysate on rotation
for 1 h at 4 C, followed by 3 5min washing in NP-40 1% lysis buffer with
protease and phosphatase inhibitors. Proteins were eluted from the beads in 100 ml
2 LDS-load (NuPAGE LDS Sample Buffer (4 ), Novex by Life Technologies)
with 100mM dithiothreitol by incubation at 70 C for 10min followed by spin
down of the beads. Samples were loaded on a 4–12% Bis-Tris gel and transferred
to a nitrocellulose membrane. Membranes were blocked for 1 h in 5% skimmed
milk (Sigma-Aldrich, 70166) TBS-T (0.05% Tween20) and immunoblotted
for the presence of IP FoxA1-FLAG or endogenous FoxA1 and co-IP
endogenous AKT with speciﬁc antibodies monoclonal a-FLAG M2-Peroxidase
(horseradish peroxidase) (1:8,000, A8592-.2MG, Sigma-Aldrich), a-FoxA1
(1:1,000, Ab23738, Abcam), a-Akt (1:15.000, C67E7 Rabbit monoclonal antibody
4691 Cell Signaling), a-Akt (1:5,000, 9272 Cell Signaling) and a-phospho-Akt
(1:6,000, Ser473 4060 Cell Signaling). The blots were developed according to the
Millipore ECL protocol.
Histology and immunoﬂuorescence histochemistry. Brains and spinal cords
of mice with EAE were dissected. Mice were either perfused and tissues ﬁxed
in 4% paraformaldehyde (PFA) and parafﬁn embedded, or tissues were embedded
in OTC compound (Sakura Finetek Denmark ApS, Værløse, Denmark) and
snap-frozen in isopentane on dry ice. Tissues were sectioned in 6–10mm slices,
were ﬁxed in 4% Paraformaldehyd (PFA) for 10min, either stained with
haematoxylin and eosin (H&E, Histolab) staining or different antibodies were used
for staining and visualized. Primary antibodies used for immunoﬂuorescence (IF)
were as follows: rabbit anti-TCR alpha (Abcam, ab18861, 1:30), rat anti-PDL1
(Abcam, ab80276, 1:200), mouse anti-FoxA1 (Millipore, 05-1466, 1:2,000) and
rabbit anti-NF200 (Sigma, N4142, 1:50). Secondary antibodies to IgG used were
as follows: goat anti mouse-Af568 (Invitrogen, A11031), goat anti-rat IgG- Af488
(Invitrogen, A11006), goat anti-rabbit IgG- Af633 (Invitrogen, A21071), goat
anti-rabbit IgG-Paciﬁc Blue (Invitrogen, P10994), all in concentration of 1:500,
Drag5-633 (BioStatus, DR05500, 5 mm) or DAPI-Paciﬁc blue (Invitrogen, D3571,
1:30,000) were used for nuclei visualization. IF images were taken with a Zeiss
LSM510 confocal scanning microscope or with IN Cell Analyzer 2200 automated
microscope. H&E images were taken with a NanoZoomer 2.0-HT digital slide
scanner or Olympus BX51 microscope.
Image quantiﬁcation. Automatic counting: IF images were taken with the
IN Cell Analyzer 2200 automated microscope. Images were processed and
quantiﬁed with ImageJ (Fiji version) and IN Cell Investigator software. The cells
were identiﬁed as TCR or NF200 positive based on negative controls and then
Table 1 | ON-TARGETplus SMARTpool siRNA sequences.
Gene Catalogue number Target sequence (50–30) Antisense (50–30)
Cd274(Pdl1) A-040760-13 UGAGCAUGAACUAAUAUGU ACAUAUUAGUUCAUGCUCA
A-040760-14 GUAUCAGCUCUCAGAUUUC GAAAUCUGAGAGCUGAUAC
A-040760-15 UCUGUAGACACCAUUUAUA UAUAAAUGGUGUCUACAGA
A-040760-16 UCAUGGUGUUGGAUUGGUG CACCAAUCCAACACCAUGA
Akt1 A-040709-14 GAUUCAUGUAGAAAACUAU AUAGUUUUCUACAUGAAUC
A-040709-15 CGUGUGACCAUGAACGAGU ACUCGUUCAUGGUCACACG
A-040709-16 GCGUGGUCAUGUACGAGAU AUCUCGUACAUGACCACGC
A-040709-17 UUCUUUGCCAACAUCGUGU ACACGAUGUUGGCAAAGAA
Foxa1 A-046238-13 CGGACGUCCUUAAGUGAAA UUUCACUUAAGGACGUCCG
A-046238-14 CUAUGGACUUAAUAUCAUG CAUGAUAUUAAGUCCAUAG
A-046238-15 GGCUCAUCCAGUGUUAAUG CAUUAACACUGGAUGAGCC
A-046238-16 GACUGUUACUUUAUUAUUG CAAUAAUAAAGUAACAGUC
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intensities in the other separate channels were measured and scored as positive
or negative using the automated software analysis.
For Inﬁltrating cells count, H&E-stained images were converted from
NDPI version (NanoZoomer) to TIFF format with ‘NDPI tools’ plugin on ImageJ.
Subsequently, the inﬁltrated areas were manually detected and a customized macro
for counting cells was run for automatic cells count.
Manual counting: For some IF staining images that were manually
quantiﬁed ImageJ was utilized. Negative controls were utilized as reference.
DAPI channel was selected with the ImageJ function ﬁnd maxima to automatically
count the total number of nucleus (cells). Next, visualizing only DAPI and far
red channel, TCR either NF200 (far red channel) were manually counted with
ImageJ manual counting function, and then, co-expression with red channel
(FoxA1) for the double positive and green channel (PDL1) for triple positive
were evaluated.
Statistical evaluations. Statistical evaluation was performed using GraphPad
Prism (GraphPad Software Inc.). Student’s t-test was used for two groups
comparison, one-way analysis of variance with post Tukey’s multiple comparisons
test and two-way analysis of variance with post Sidak’s multiple comparisons
test were used for more than two groups comparison. Non-parametric
Mann–Whitney test was used for EAE score and IF staining quantiﬁcation data.
A value of Po0.05 was considered signiﬁcant.
Data availability. All relevant data are available from the authors on request.
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